Pgap2 Antikörper (AA 45-114)
Kurzübersicht für Pgap2 Antikörper (AA 45-114) (ABIN7163908)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 45-114
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Post-GPI attachment to proteins factor 2 protein (45-114AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Pgap2 (Post-GPI Attachment To Proteins 2 (Pgap2))
-
Andere Bezeichnung
- PGAP2
-
Hintergrund
-
Background: Involved in the lipid remodeling steps of GPI-anchor maturation. Required for stable expression of GPI-anchored proteins at the cell surface (By similarity).
Aliases: PGAP2 antibody, FRAG1 antibody, Post-GPI attachment to proteins factor 2 antibody, FGF receptor-activating protein 1 antibody
-
UniProt
- Q9UHJ9
Target
-